Understanding HoLEP - Advances in Prostate Treatment - Dr Jeevagan Murugesan

Published Date: 01 Mar 2023

Benign prostatic hyperplasia (BPH) is a condition in which the prostate gland enlarges, causing problems or obstruction in urination...

Read Full News

Latest News

Doc Murdered 8 Patients? RFK Jr. Will 'Cost Lives'; $412M in Penile Injection Case

Health news and commentary gathered by MedPage Today staff

FDA Approves Novel Treatment for UTIs

New oral antibiotic gets a nod for uncomplicated urinary tract infections

Mission Health Urologists Disappear.

Following the takeover by HCA, experts identify the most recent departures.

More then ever, the healthcare industry needs qualified expert witnesses.

It can offer a fresh challenge as well as be the appropriate course of action in certain situations.

The medication used to treat sexual desire disorder in women also helps men.

Melanoside is associated with several beneficial effects on male sexual function.

Combination Treatments for Erectile Dysfunction: Uneven Outcomes.

When treating severe ED, one combination worked well; when treating milder ED, it did not.

Todays Updates

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Addressing Fibromyalgia Sleep and Pain With TNX-102 SL Approval: Q&A With Philip Mease, MD Philip J. Mease, MD

Mease discussed his hopes for the new approval's impact on the fibromyalgia field.

7 Rheumatology Headlines You Missed in September 2025 Victoria Johnson

The rheumatology month in review emphasizes new approvals and the latest comparative research.

Q3 2025 Recap: 7 Top FDA Approvals to Know Victoria Johnson

Q3 2025 saw several new first targeted therapies for rare and more individualized indications in a number of fields.

Q3 2025 Recap: Rheumatology News and Updates Victoria Johnson

Q3 2025 saw a number of exciting approvals and data on promising therapies in development.

Bridging the Treatment Gap in Pediatric Psoriasis and PsA With Guselkumab, With Vimal H. Prajapati, MD Vimal H. Prajapati, MD

Prajapati discussed the impact of the expanded approval of guselkumab to pediatric PsO and psoriatic arthritis.

Sonelokimab Demonstrates Psoriatic Arthritis Improvements Over Placebo Victoria Johnson

Sonelokimab meets ACR50 primary endpoint in a phase 2 trial.

Todays Updates

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Addressing Fibromyalgia Sleep and Pain With TNX-102 SL Approval: Q&A With Philip Mease, MD Philip J. Mease, MD

Mease discussed his hopes for the new approval's impact on the fibromyalgia field.

7 Rheumatology Headlines You Missed in September 2025 Victoria Johnson

The rheumatology month in review emphasizes new approvals and the latest comparative research.

Q3 2025 Recap: 7 Top FDA Approvals to Know Victoria Johnson

Q3 2025 saw several new first targeted therapies for rare and more individualized indications in a number of fields.

Q3 2025 Recap: Rheumatology News and Updates Victoria Johnson

Q3 2025 saw a number of exciting approvals and data on promising therapies in development.

Bridging the Treatment Gap in Pediatric Psoriasis and PsA With Guselkumab, With Vimal H. Prajapati, MD Vimal H. Prajapati, MD

Prajapati discussed the impact of the expanded approval of guselkumab to pediatric PsO and psoriatic arthritis.

Sonelokimab Demonstrates Psoriatic Arthritis Improvements Over Placebo Victoria Johnson

Sonelokimab meets ACR50 primary endpoint in a phase 2 trial.

Latest News

Health news and commentary gathered by MedPage Today staff

New oral antibiotic gets a nod for uncomplicated urinary tract infections

Following the takeover by HCA, experts identify the most recent departures.

It can offer a fresh challenge as well as be the appropriate course of action in certain situations.

Melanoside is associated with several beneficial effects on male sexual function.

When treating severe ED, one combination worked well; when treating milder ED, it did not.

News All Time

Even in those with HIV, a single dose of antibiotics was able to cure early syphilis.

In a randomized trial, one dosage showed no worse results than a triple-dose regimen.

Removing Cancer Survivors From Oncologic Treatment.

A new approach to care is required.

Cabazitaxel Lower-Dose Schedule Is Viable for Elderly Patients With mCRPC.

Neutropenia of grade three or above, with a twelve-fold reduction in neutropenic consequences.

AR-Pathway Inhibitor Switch for mCRPC is Superseded by Radionuclide Therapy.

With 177Lu-PSMA-617, the time to radiographic progression was doubled.

An RCT Supports HIF-2a Inhibition in Advanced RCC.

Belzutifan outperforms everolimus in the event of immunotherapy-TKI failure.

CAR T-Cell Therapy for Renal Cell Carcinoma: "We're Not There Yet".

Possibility of standard of care following current therapies, but significant barriers still need to be overcome.

Finding New Routes to Improve Renal Cell Carcinoma Outcomes.

It is necessary to intervene at several stages of the cancer immunity cycle in order to build on recent successes.

In severe cases of renal cell carcinoma, tyrosine kinase inhibitor activity is present.

Reactions to the "special medication" zanzalintinib in patients exposed and not exposed to cabozantinib.

Dietary inflammation is associated with the development of urologic cancers.

In health research, the relationship between dietary habits and cancer risks is still a major focus. The has been the subject of a recent meta-analysis.

In infants, laparoscopic robotic pyeloplasty is safe and has a success rate comparable to open surgery.

The results of minimally invasive pyeloplasty (MIP) for the primary cause, ureteropelvic junction obstruction (UPJO), were examined in a recent study.

Medical Bulletin November 30, 2023.

The top medical stories of the day are as follows: ADHD increases the risk of car crashes in older adults. ADHD is a neurodevelopmental disorder that is chronic and has symptoms.

The only viable solution for stress urinary incontinence with mesh slings is informed decision-making.

UK: A recent study thoroughly examined the short- and long-term mesh sling complications reported in European Urology Focus.

Black people who consume a few servings of whole grains have been shown to experience a slower rate of memory loss.

A slower rate of memory loss may be experienced by Black individuals who consume more whole grain-containing foods, such as popcorn, quinoa, and some breads and cereals.

Wellness Bulletin 25/November/2023.

Here are the top health stories for the day:Doctors performing 'Two Finger Test' will be guilty of misconductReiterating the fact that the Supreme.

Do Patients Follow Up on Recommended Care Following Telehealth Visits?

Experts offer tips for improving compliance after telehealth visits. How many patients follow through on your recommendations after they've finished their visit? Does it matter whether you saw them virtually or in person?

Details of the MCC withdrawal of two MCh Urology seats from the Round 1 NEET SS Counseling Seat Matrix are provided.

New Delhi: MCH Urology's seats in Round 1 NEET have been withdrawn, as announced by the Medical Counselling Committee (MCC) in a recent notice.

Recommended News For You

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

Patient Endured 9 Years of Chemotherapy for Cancer He Never Had

enhancing survivors of brain tumors' quality of life.

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

Recommended Articles For You

Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients 

Different Types of Blood Dyscrasias  

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential 

Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

2.

Brain cancer: a Q&A session.

3.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

4.

Daily physical activity, even at light intensities, linked to lower cancer risk

5.

Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer

1.

A Revolutionary Guide to Calculating Absolute Neutrophil Counts

2.

Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research

3.

Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective

4.

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment

5.

Synovial Sarcoma of Female Urethra: Case Report and Literature Review

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

3.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot